MoneyWorks4Me

Lactose India - Quaterly Results

02 Nov 2023 Evaluate
An increase of about 85.50% to Rs. 244.26 millions in the topline was observed for the quarter ended September 2023. The topline stood at Rs. 131.68 millions during the similar quarter previous year.The Net Profit of the company reported a remarkable increase of 826.44% to Rs. 8.06  millions  from Rs. 0.87 millions in previous same quarter.OP of the company witnessed a marginal growth to 36.52 millions from 25.56 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 244.26 131.68 85.50 518.93 227.92 127.68 657.96 459.39 43.22
Other Income 2.57 1.99 29.15 5.38 4.24 26.89 7.29 5.79 25.91
PBIDT 36.52 25.56 42.88 77.02 50.64 52.09 121.85 128.40 -5.10
Interest 13.14 13.15 -0.08 28.66 25.56 12.13 60.36 51.16 17.98
PBDT 23.38 12.41 88.40 48.36 25.08 92.82 61.49 77.24 -20.39
Depreciation 11.98 11.67 2.66 23.89 23.27 2.66 46.85 45.59 2.76
PBT 11.40 0.74 1440.54 24.47 1.81 1251.93 14.64 31.65 -53.74
TAX 3.34 -0.13 -2669.23 6.84 0.07 9671.43 2.56 7.16 -64.25
Deferred Tax 1.42 0.38 273.68 2.74 0.48 470.83 0.77 1.46 -47.26
PAT 8.06 0.87 826.44 17.63 1.74 913.22 12.08 24.49 -50.67
Equity 125.89 125.89 0.00 125.89 125.89 0.00 125.89 125.89 0.00
PBIDTM(%) 14.95 19.41 -22.97 14.84 22.22 -33.20 18.52 27.95 -33.74
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..